PolyPid (PYPD)
(Delayed Data from NSDQ)
$3.47 USD
-0.04 (-1.14%)
Updated Oct 11, 2024 12:23 PM ET
After-Market: $3.58 +0.11 (3.17%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (89 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.55 | 9.99 |
Current Quarter Estimate | -1.07 | 0.07 | 63.00 |
Year Ago Quarter Estimate | -3.40 | 0.12 | 52.25 |
Next Quarter Estimate | -0.86 | -2.02 | 66.00 |
Next Year Estimate | -2.21 | 11.91 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 74.07 | 19.10 | 15.67 |
Next Year | 49.66 | 16.90 | 11.34 |
Last 5 Years | NA | 5.00 | 8.10 |
Next 5 Years | NA | 21.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.52 |
Price/Book (MRQ) | 10.40 | 1.52 |
Price/Cash Flow (MRFY) | NA | 8.63 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -203.98% |
Return on Equity (TTM) | -969.85% | -81.98% |
Debt to Equity (MRQ) | NA | 0.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.